文献速递神经头颈MR

静脉窦支架置入后特发性颅内高压MRI表现演变

Evolution of MRI Findings in Patients with Idiopathic Intracranial Hypertension after Venous Sinus Stenting.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-10-07

结果显示尽管颅内压和症状显著改善,仅后部眼球受累、视神经鞘直径和颈部皮下脂肪厚度减少,且视神经相关改变与症状改善相关。

要点

  • 静脉窦支架置入后6个月,视神经鞘直径和后部眼球受累可显著改善。
  • 视神经鞘直径缩小与恶心/呕吐改善相关,后部眼球受累改善与视乳头水肿减轻相关。
  • 多数MRI征象(如空蝶鞍、扁桃体下疝)在颅内压正常后仍持续存在。

关键影像表现/征象

  • 后部眼球受累(后部巩膜变平/视神经突出)比例从61.5%降至15.4%(P=.001)。
  • 视神经鞘直径从6.8 mm降至6.1 mm(P<.001)。
  • 颈部皮下脂肪厚度从8.9 mm降至7.4 mm(P=.001)。
  • 空蝶鞍、Meckel腔、扁桃体下疝、脑室、枕部导静脉等表现未见同步显著减少。

诊断标准与关键数值

  • 脑脊液开放压力从31 cm H2O降至21 cm H2O(P=.005)。
  • 跨狭窄压力梯度从22.5 mm Hg降至1.5 mm Hg(P=.002)。
  • 右侧视神经鞘直径减小与恶心/呕吐改善相关(r=0.592,P=.033)。
  • 左侧视神经鞘直径减小与恶心/呕吐改善相关(r=0.718,P=.006)。
  • 后部眼球受累改善与视乳头水肿减轻相关(r=0.775,P=.003);枕部导静脉直径减小与头痛频率降低相关(r=0.74,P=.035);跨狭窄压力梯度下降与空蝶鞍减少(r=0.625,P=.022)和小脑扁桃体下疝回缩(r=0.662,P=.019)相关。

临床应用与阅片要点

  • 阅片时关注视神经鞘直径和后部眼球受累的变化,这些征象可能反映静脉窦支架治疗成功。
  • 注意空蝶鞍、扁桃体下疝等征象在颅内压正常后仍可能持续存在,不应误判为治疗失败。

局限性

  • 仅评估6个月随访,长期演变未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The correlation between imaging findings and clinical status in patients with idiopathic intracranial hypertension is unclear. We aimed to examine the evolution of idiopathic intracranial hypertension-related MR imaging findings in patients treated with venous sinus stent placement.

MATERIALS AND METHODS: Thirteen patients with idiopathic intracranial hypertension (median age, 26.9 years) were assessed for changes in the CSF opening pressure, transstenotic pressure gradient, and symptoms after venous sinus stent placement. Optic nerve sheath diameter, posterior globe flattening and/or optic nerve protrusion, empty sella, the Meckel cave, tonsillar ectopia, the ventricles, the occipital emissary vein, and subcutaneous fat were evaluated on MR imaging before and 6 months after venous sinus stent placement. Data are expressed as percentages, medians, or correlation coefficients (r) with P values.

RESULTS: Although all patients showed significant reductions of the CSF opening pressure (31 versus 21 cm H2O; P = .005) and transstenotic pressure gradient (22.5 versus 1.5 mm Hg; P = .002) and substantial improvement of clinical symptoms 6 months after venous sinus stent placement, a concomitant reduction was observed only for posterior globe involvement (61.5% versus 15.4%; P = .001), optic nerve sheath diameter (6.8 versus 6.1 mm; P < .001), and subcutaneous neck fat (8.9 versus 7.4 mm; P = .001). Strong correlations were observed between decreasing optic nerve sheath diameters and improving nausea/emesis (right optic nerve sheath diameter, r = 0.592, P = .033; left optic nerve sheath diameter, r = 0.718, P = .006), improvement of posterior globe involvement and decreasing papilledema (r = 0.775, P = .003), and decreasing occipital emissary vein diameter and decreasing headache frequency (r = 0.74, P = .035). Decreasing transstenotic pressure gradient at 6 months strongly correlated with decreasing empty sella (r = 0.625, P = .022) and regressing cerebellar ectopia (r = 0.662, P = .019).

CONCLUSIONS: Most imaging findings persist long after normalization of intracranial pressure and clinical improvement. However, MR imaging findings related to the optic nerve may reflect treatment success.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Belachew NF, Almiri W, Encinas R, et al. Evolution of MRI Findings in Patients with Idiopathic Intracranial Hypertension after Venous Sinus Stenting. AJNR Am J Neuroradiol. 2021. PMID: 34620591. doi:10.3174/ajnr.A7311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。